» Articles » PMID: 11068197

Left Prefrontal Activation Predicts Therapeutic Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression

Overview
Journal Psychiatry Res
Specialty Psychiatry
Date 2000 Nov 9
PMID 11068197
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

There is evidence that repetitive transcranial magnetic stimulation (rTMS) applied to the prefrontal cortex has antidepressive properties. In the present study we evaluated the clinical status and the hemodynamic responses during mental work in the prefrontal cortex before therapeutic rTMS. Twelve patients diagnosed with major depression (DSM-IV) were randomized in a sham-controlled cross-over treatment protocol of 4 weeks' duration consisting of two periods of 5 days with rTMS separated by 9 days of no stimulation. rTMS (10 Hz) was applied to the left dorsolateral prefrontal cortex. Hemodynamic changes in the prefrontal cortex during mental work were evaluated by multi-site near-infrared spectroscopy (NIRS). Scores on the Hamilton Depression Rating Scale (HAMD) decreased significantly by -5.4 points after 5 days of active stimulation, whereas it did not change (+1.6 points) after sham stimulation. Absence of a task-related increase of total hemoglobin concentrations at the stimulation site (P<0.005), but not at other locations, before the first active rTMS significantly predicted the clinical response to active rTMS. Clinical benefits of rTMS are predicted by low local hemodynamic responses and support the idea of activation-dependent targeting of rTMS location.

Citing Articles

Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation Across Mental Disorders: A Systematic Review and Dose-Response Meta-Analysis.

Sabe M, Hyde J, Cramer C, Eberhard A, Crippa A, Brunoni A JAMA Netw Open. 2024; 7(5):e2412616.

PMID: 38776083 PMC: 11112448. DOI: 10.1001/jamanetworkopen.2024.12616.


A Systematic Review Assessing Patient-Related Predictors of Response to Transcranial Magnetic Stimulation in Major Depressive Disorder.

Gonterman F Neuropsychiatr Dis Treat. 2023; 19:565-577.

PMID: 36919097 PMC: 10008378. DOI: 10.2147/NDT.S388164.


Current opinions on the present and future use of functional near-infrared spectroscopy in psychiatry.

Li R, Hosseini H, Saggar M, Balters S, Reiss A Neurophotonics. 2023; 10(1):013505.

PMID: 36777700 PMC: 9904322. DOI: 10.1117/1.NPh.10.1.013505.


Optical neuroimaging: advancing transcranial magnetic stimulation treatments of psychiatric disorders.

Jiang S, Carpenter L, Jiang H Vis Comput Ind Biomed Art. 2022; 5(1):22.

PMID: 36071259 PMC: 9452613. DOI: 10.1186/s42492-022-00119-y.


rTMS Therapy Reduces Hypofrontality in Patients With Depression as Measured by fNIRS.

Kawabata Y, Imazu S, Matsumoto K, Toyoda K, Kawano M, Kubo Y Front Psychiatry. 2022; 13:814611.

PMID: 35815029 PMC: 9257165. DOI: 10.3389/fpsyt.2022.814611.